1. Home
  2. QNRX vs JZ Comparison

QNRX vs JZ Comparison

Compare QNRX & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$8.16

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Logo Jianzhi Education Technology Group Company Limited

JZ

Jianzhi Education Technology Group Company Limited

HOLD

Current Price

$1.00

Market Cap

12.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNRX
JZ
Founded
2018
2011
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
12.6M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
QNRX
JZ
Price
$8.16
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.0K
324.6K
Earning Date
05-12-2026
10-16-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.25
52 Week High
$41.80
$2.93

Technical Indicators

Market Signals
Indicator
QNRX
JZ
Relative Strength Index (RSI) 45.27 72.16
Support Level $8.03 $1.43
Resistance Level $8.97 $1.90
Average True Range (ATR) 0.41 0.16
MACD 0.02 0.05
Stochastic Oscillator 47.29 92.56

Price Performance

Historical Comparison
QNRX
JZ

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

Share on Social Networks: